BRIDGER MANAGEMENT, LLC - Q2 2021 holdings

$1.07 Billion is the total value of BRIDGER MANAGEMENT, LLC's 44 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 38.1% .

 Value Shares↓ Weighting
GDDY  GODADDY INCcl a$72,373,000
+12.0%
832,2530.0%6.75%
+12.0%
CZR  CAESARS ENTERTAINMENT INC NE$63,843,000
+18.6%
615,3530.0%5.96%
+18.6%
MS  MORGAN STANLEY$53,555,000
+18.1%
584,0920.0%5.00%
+18.0%
POST  POST HLDGS INC$53,052,000
+2.6%
489,0980.0%4.95%
+2.5%
UBER BuyUBER TECHNOLOGIES INC$50,942,000
+0.3%
1,016,409
+9.1%
4.75%
+0.2%
ALC  ALCON AG$49,260,000
+0.1%
701,1150.0%4.60%
+0.0%
ROST  ROSS STORES INC$47,600,000
+3.4%
383,8680.0%4.44%
+3.4%
CNC NewCENTENE CORP DEL$45,990,000630,600
+100.0%
4.29%
NTRA BuyNATERA INC$44,688,000
+13.2%
393,620
+1.3%
4.17%
+13.2%
VRSN  VERISIGN INC$43,765,000
+14.6%
192,2140.0%4.08%
+14.5%
LKQ  LKQ CORP$40,281,000
+16.3%
818,3870.0%3.76%
+16.2%
CHTR  CHARTER COMMUNICATIONS INC Ncl a$39,650,000
+16.9%
54,9590.0%3.70%
+16.8%
SHC SellSOTERA HEALTH CO$36,501,000
-6.2%
1,506,454
-3.4%
3.41%
-6.3%
CLVT BuyCLARIVATE PLC$33,578,000
+48.1%
1,219,680
+42.0%
3.13%
+48.0%
GDS  GDS HLDGS LTDsponsored ads$31,006,000
-3.2%
395,0250.0%2.89%
-3.2%
FTDR  FRONTDOOR INC$29,730,000
-7.3%
596,7580.0%2.78%
-7.3%
PODD BuyINSULET CORP$27,491,000
+10.6%
100,145
+5.1%
2.57%
+10.5%
IRWD SellIRONWOOD PHARMACEUTICALS INC$26,192,000
-17.9%
2,035,114
-28.7%
2.44%
-17.9%
ATRA SellATARA BIOTHERAPEUTICS INC$20,607,000
-14.1%
1,325,188
-20.6%
1.92%
-14.1%
ETSY  ETSY INC$20,124,000
+2.1%
97,7630.0%1.88%
+2.0%
ALNY SellALNYLAM PHARMACEUTICALS INC$18,868,000
-41.0%
111,304
-50.9%
1.76%
-41.0%
AMWL SellAMERICAN WELL CORPcl a$17,403,000
-38.5%
1,383,417
-15.1%
1.62%
-38.5%
ZGNX  ZOGENIX INC$16,413,000
-11.5%
949,8130.0%1.53%
-11.5%
CUTR  CUTERA INC$15,954,000
+63.2%
325,4000.0%1.49%
+63.1%
TEVA  TEVA PHARMACEUTICAL INDS LTDsponsored ads$14,850,000
-14.2%
1,500,0000.0%1.39%
-14.2%
LBRDA  LIBERTY BROADBAND CORP$14,771,000
+15.9%
87,8330.0%1.38%
+15.8%
NVRO NewNEVRO CORP$14,457,00087,200
+100.0%
1.35%
HCA SellHCA HEALTHCARE INC$14,185,000
-67.4%
68,613
-70.3%
1.32%
-67.4%
PVG  PRETIUM RES INC$13,445,000
-7.8%
1,406,4120.0%1.26%
-7.9%
PSPCU NewPOST HOLDINGS PARTNERING CORunit 99/99/9999$12,988,0001,250,000
+100.0%
1.21%
ZBH SellZIMMER BIOMET HOLDINGS INC$12,008,000
-15.8%
74,670
-16.2%
1.12%
-15.8%
LIVN NewLIVANOVA PLC$10,648,000126,600
+100.0%
0.99%
AVANU  AVANTI ACQUISITION CORPunit 99/99/9999$10,230,000
-1.2%
1,000,0000.0%0.96%
-1.2%
DXCM BuyDEXCOM INC$9,374,000
+54.3%
21,953
+29.9%
0.88%
+54.3%
TGTX SellTG THERAPEUTICS INC$8,503,000
-31.3%
219,197
-14.7%
0.79%
-31.3%
QTRX BuyQUANTERIX CORP$7,494,000
+65.9%
127,749
+65.4%
0.70%
+65.6%
APLS SellAPELLIS PHARMACEUTICALS INC$7,332,000
-47.3%
116,015
-64.2%
0.68%
-47.3%
CHFWU  CONSONANCE HFW ACQUISITION Cunit 99/99/9999$7,280,000
+6.6%
700,0000.0%0.68%
+6.4%
NEXI  NEXIMMUNE INC$6,528,000
-14.5%
400,0000.0%0.61%
-14.6%
ALEC NewALECTOR INC$4,247,000203,900
+100.0%
0.40%
SEER NewSEER INC$1,891,00057,700
+100.0%
0.18%
OLK NewOLINK HLDG ABsponsored ads$1,581,00045,925
+100.0%
0.15%
NAUT NewNAUTILUS BIOTECHNOLOGY INC$576,00057,000
+100.0%
0.05%
MYPSW NewPLAYSTUDIOS INC*w exp 06/17/202$261,000141,105
+100.0%
0.02%
ACACW ExitACIES ACQUISITION CORP*w exp 11/30/202$0-299,999
-100.0%
-0.04%
ExitDERMTECH INC$0-122,877
-100.0%
-0.58%
ACAC ExitACIES ACQUISITION CORPcl a$0-899,997
-100.0%
-0.84%
SQZ ExitSQZ BIOTECHNOLOGIES CO$0-807,827
-100.0%
-0.93%
DRNA ExitDICERNA PHARMACEUTICALS INC$0-588,910
-100.0%
-1.41%
FCNCA ExitFIRST CTZNS BANCSHARES INC Ncl a$0-20,000
-100.0%
-1.56%
MSFT ExitMICROSOFT CORP$0-114,289
-100.0%
-2.52%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Export BRIDGER MANAGEMENT, LLC's holdings